Dyne Therapeutics, Inc.DYNNASDAQ
Loading
Total Costs & Expenses Over TimeContracting
Percentile Rank57
3Y CAGR+39.9%
5Y CAGR+51.5%
Studio
Year-over-Year Change

Total of all costs and expenses

3Y CAGR
+39.9%/yr
vs +144.4%/yr prior
5Y CAGR
+51.5%/yr
Recent deceleration
Acceleration
-104.5pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
8x
Strong expansion
Streak
7 yr
Consecutive growthContracting
PeriodValueYoY Change
TTM$468.18M+36.1%
2024$343.89M+42.0%
2023$242.16M+41.6%
2022$170.96M+14.0%
2021$150.03M+155.8%
2020$58.65M+324.2%
2019$13.83M+188.3%
2018$4.79M-99.8%
2017$3.12B+27.8%
2016$2.44B-